Subarachnoid hemorrhage and the distribution of drugs delivered into the cerebrospinal fluid

Laboratory investigation

View More View Less
  • 1 Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, and
  • | 2 Section of Neuroradiology, Diagnostic Radiology Department, Warren Grant Magnuson Clinical Center, National Institutes of Health, Bethesda, Maryland;
  • | 3 Department of Neurosurgery, Geneva University Hospital, Geneva, Switzerland; and
  • | 4 Department of Neurological Surgery, University of Virginia Health System, Charlottesville, Virginia
Restricted access

Purchase Now

USD  $45.00

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $515.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $612.00
Print or Print + Online

Object

Investigators in experimental and clinical studies have used the intrathecal route to deliver drugs to prevent or treat vasospasm. However, a clot near an artery or arteries after subarachnoid hemorrhage (SAH) may hamper distribution and limit the effects of intrathecally delivered compounds. In a primate model of right middle cerebral artery (MCA) SAH, the authors examined the distribution of Isovue-M 300 and 3% Evans blue after infusion into the cisterna magna CSF.

Methods

Ten cynomolgus monkeys were assigned to SAH and sham SAH surgery groups (5 in each group). Monkeys received CSF injections as long as 28 days after SAH and were killed 3 hours after the contrast/Evans blue injection. The authors assessed the distribution of contrast material on serial CT within 2 hours after contrast injection and during autopsy within 3 hours after Evans blue staining.

Results

Computed tomography cisternographies showed no contrast in the vicinity of the right MCA (p < 0.05 compared with left); the distribution of contrast surrounding the entire right cerebral hemisphere was substantially reduced. Postmortem analysis demonstrated much less Evans blue staining of the right hemisphere surface compared with the left. Furthermore, the Evans blue dye did not penetrate into the right sylvian fissure, which occurred surrounding the left MCA. The authors observed the same pattern of changes and differences in contrast distribution between SAH and sham SAH animals and between the right and the left hemispheres on Days 1, 3, 7, 14, 21, and 28 after SAH.

Conclusions

Intrathecal drug distribution is substantially limited by SAH. Thus, when using intrathecal drug delivery after SAH, vasoactive drugs are unlikely to reach the arteries that are at the highest risk of delayed cerebral vasospasm.

Abbreviations used in this paper:

ANOVA = analysis of variance; ICA = internal carotid artery; MCA = middle cerebral artery; SAH = subarachnoid hemorrhage; tPA = tissue plasminogen activator.

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $515.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $612.00
  • 1

    Adams C, Treatment with sodium nitroprusside. Wilkins R: Cerebral Arterial Spasm: Proceedings of the Second International Workshop Baltimore, Williams & Wilkins, 1981. 181185

    • Search Google Scholar
    • Export Citation
  • 2

    Aihara Y, , Jahromi BS, , Yassari R, , Sayama T, & Macdonald RL: Effects of a nitric oxide donor on and correlation of changes in cyclic nucleotide levels with experimental vasospasm. Neurosurgery 52:661667, 2003

    • Search Google Scholar
    • Export Citation
  • 3

    Amin-Hanjani S, , Ogilvy C, & Barker F II: Does intracisternal thrombolysis prevent vasospasm after aneurysmal subarachnoid hemorrhage? A meta-analysis. Neurosurgery 54:326335, 2004

    • Search Google Scholar
    • Export Citation
  • 4

    Asano T, , Sasaki T, , Koide T, , Takakura K, & Sano K: Experimental evaluation of the beneficial effect of an antioxidant on cerebral vasospasm. Neurol Res 6:4953, 1984

    • Search Google Scholar
    • Export Citation
  • 5

    Auer LM: Preventive nimodipine and acute aneurysm surgery. Heading for the control of complications after aneurysmal subarachnoid hemorrhage. Neurochirurgia (Stuttg) 28:87 92, 1985

    • Search Google Scholar
    • Export Citation
  • 6

    Azmi-Ghadimi H, , Heary RF, , Farkas JE, & Hunt CD: Use of intraventricular tissue plasminogen activator and Guglielmi detachable coiling for the acute treatment of casted ventricles from cerebral aneurysm hemorrhage: two technical case reports. Neurosurgery 50:421425, 2002

    • Search Google Scholar
    • Export Citation
  • 7

    Boullin DJ, , Adams CB, , Mohan J, , Green AR, , Hunt TM, & du Boulay GH, et al.: Effects of intracranial dopamine perfusion: behavioural arousal and reversal of cerebral arterial spasm following surgery for clipping of ruptured cerebral aneurysm. Proc R Soc Med 70:Suppl 2 5570, 1977

    • Search Google Scholar
    • Export Citation
  • 8

    Cosentino F, , McMahon EG, , Carter JS, & Katusic ZS: Effect of endothelinA-receptor antagonist BQ-123 and phosphoramidon on cerebral vasospasm. J Cardiovasc Pharmacol 22:Suppl 8 S332S335, 1993

    • Search Google Scholar
    • Export Citation
  • 9

    Dalbasti T, , Karabiyikoglu M, , Ozdamar N, , Oktar N, & Cagli S: Efficacy of controlled-release papaverine pellets in preventing symptomatic cerebral vasospasm. J Neurosurg 95:4450, 2001

    • Search Google Scholar
    • Export Citation
  • 10

    Egemen N, , Baskaya MK, , Turker RK, , Unlu A, , Caglar S, & Guven C, et al.: Protection by Iloprost (stable analogue of prostacyclin) of endothelial damage due to chronic vasospasm in dogs: an electron microscope study. Neurol Res 17:301306, 1995

    • Search Google Scholar
    • Export Citation
  • 11

    Egemen N, , Turker RK, , Sanlidilek U, , Zorlutuna A, , Bilgic S, & Baskaya M, et al.: The effect of intrathecal sodium nitroprusside on severe chronic vasospasm. Neurol Res 15:310315, 1993

    • Search Google Scholar
    • Export Citation
  • 12

    Ezura M, , Takahashi A, , Ogasawara K, & Yoshimoto T: Intra-aneurysmal GDC embolization followed by intrathecal tPA administration for poor-grade basilar tip aneurysm. Surg Neurol 47:144148, 1997

    • Search Google Scholar
    • Export Citation
  • 13

    Findlay JM, , Kassell NF, , Weir BK, , Haley EC Jr, , Kongable G, & Germanson T, et al.: A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm. Neurosurgery 37:168178, 1995

    • Search Google Scholar
    • Export Citation
  • 14

    Findlay JM, , Weir BK, , Gordon P, , Grace M, & Baughman R: Safety and efficacy of intrathecal thrombolytic therapy in a primate model of cerebral vasospasm. Neurosurgery 24:491 498, 1989

    • Search Google Scholar
    • Export Citation
  • 15

    Findlay JM, , Weir BK, , Kanamaru K, , Grace M, & Baughman R: The effect of timing of intrathecal fibrinolytic therapy on cerebral vasospasm in a primate model of subarachnoid hemorrhage. Neurosurgery 26:201206, 1990

    • Search Google Scholar
    • Export Citation
  • 16

    Findlay JM, , Weir BK, , Kanamaru K, , Grace M, , Gordon P, & Baughman R, et al.: Intrathecal fibrinolytic therapy after subarachnoid hemorrhage: dosage study in a primate model and review of the literature. Can J Neurol Sci 16:2840, 1989

    • Search Google Scholar
    • Export Citation
  • 17

    Findlay JM, , Weir BK, , Kassell NF, , Disney LB, & Grace MG: Intracisternal recombinant tissue plasminogen activator after aneurysmal subarachnoid hemorrhage. J Neurosurg 75:181 188, 1991

    • Search Google Scholar
    • Export Citation
  • 18

    Findlay JM, , Weir BK, , Steinke D, , Tanabe T, , Gordon P, & Grace M: Effect of intrathecal thrombolytic therapy on subarachnoid clot and chronic vasospasm in a primate model of SAH. J Neurosurg 69:723735, 1988

    • Search Google Scholar
    • Export Citation
  • 19

    Fujiwara K, , Mikawa S, & Ebina T: [Continuous intrathecal administration of nicardipine using a portable infusion pump system for management of vasospasm after subarachnoid hemorrhage.]. No Shinkei Geka 29:2330, 2001. (Jpn)

    • Search Google Scholar
    • Export Citation
  • 20

    Fukuoka H, , Takagi T, , Nagai H, , Hotta K, , Fujimoto S, & Naitoh K: [Relief of experimental cerebral vasospasm by the intrathecal administration of a calcium antagonist (diltiazem)—in comparison with intra-arterial administration.]. No Shinkei Geka 13:839843, 1985. (Jpn)

    • Search Google Scholar
    • Export Citation
  • 21

    Gabikian P, , Clatterbuck R, , Eberhart C, , Tyler B, , Tierney T, & Tamargo R: Prevention of experimental cerebral vasospasm by intracranial delivery of a nitric oxide donor from a controlled-release polymer: toxicity and efficacy studies in rabbits and rats. Stroke 33:26812686, 2002

    • Search Google Scholar
    • Export Citation
  • 22

    Gioia AE, , White RP, , Bakhtian B, & Robertson JT: Evaluation of the efficacy of intrathecal nimodipine in canine models of chronic cerebral vasospasm. J Neurosurg 62:721728, 1985

    • Search Google Scholar
    • Export Citation
  • 23

    Goksel HM, , Ozum U, & Oztoprak I: The therapeutic effect of continuous intracisternal L-Arginine infusion on experimental cerebral vasospasm. Acta Neurochir (Wien) 143:277285, 2001

    • Search Google Scholar
    • Export Citation
  • 24

    Goodson K, , Lapointe M, , Monroe T, & Chalela JA: Intraventricular nicardipine for refractory cerebral vasospasm after subarachnoid hemorrhage. Neurocrit Care 8:247252, 2008

    • Search Google Scholar
    • Export Citation
  • 25

    Hamada J, , Kai Y, , Morioka M, , Yano S, , Mizuno T, & Hirano T, et al.: Effect on cerebral vasospasm of coil embolization followed by microcatheter intrathecal urokinase infusion into the cisterna magna: a prospective randomized study. Stroke 34:25492554, 2003

    • Search Google Scholar
    • Export Citation
  • 26

    Hamada J, , Mizuno T, , Kai Y, , Morioka M, & Ushio Y: Microcatheter intrathecal urokinase infusion into cisterna magna for prevention of cerebral vasospasm: preliminary report. Stroke 31:21412148, 2000

    • Search Google Scholar
    • Export Citation
  • 27

    Hariton GB, , Findlay JM, , Weir BK, , Kasuya H, , Grace MG, & Mielke BW: Comparison of intrathecal administration of urokinase and tissue plasminogen activator on subarachnoid clot and chronic vasospasm in a primate model. Neurosurgery 33:691697, 1993

    • Search Google Scholar
    • Export Citation
  • 28

    Heidrich R, , Markwardt F, , Endler S, & Hindersin P: Antifibrinolytic therapy of subarachnoid hemorrhage by intrathecal administration of p-aminomethylbenzoic acid. J Neurol 219:8385, 1978

    • Search Google Scholar
    • Export Citation
  • 29

    Hindersin P, , Endler S, , Heidrich R, , Lehmann W, & Dietrich J: [Current status of intrathecal antifibrinolytic therapy with paminomethylbenzoic acid (PAMBA) in subarachnoid hemorrhages.]. Psychiatr Neurol Med Psychol (Leipz) 37:686689, 1985. (Ger)

    • Search Google Scholar
    • Export Citation
  • 30

    Hino A, , Weir BK, , Macdonald RL, , Thisted RA, , Kim CJ, & Johns LM: Prospective, randomized, double-blind trial of BQ-123 and bosentan for prevention of vasospasm following subarachnoid hemorrhage in monkeys. J Neurosurg 83:503509, 1995

    • Search Google Scholar
    • Export Citation
  • 31

    Inoue T, , Shimizu H, , Kaminuma T, , Tajima M, , Watabe K, & Yoshimoto T: Prevention of cerebral vasospasm by calcitonin gene-related peptide slow-release tablet after subarachnoid hemorrhage in monkeys. Neurosurgery 1996:984990, 1996

    • Search Google Scholar
    • Export Citation
  • 32

    Ishida T, , Takanashi Y, & Kiwada H: Safe and efficient drug delivery system with liposomes for intrathecal application of an antivasospastic drug, fasudil. Biol Pharm Bull 29:397402, 2006

    • Search Google Scholar
    • Export Citation
  • 33

    Julow J: Prevention of subarachnoid fibrosis after subarachnoid haemorrhage with urokinase. Scanning electron microscopic study in the dog. Acta Neurochir (Wien) 51:5163, 1979

    • Search Google Scholar
    • Export Citation
  • 34

    Kajita Y, , Suzuki Y, , Oyama H, , Tanazawa T, , Takayasu M, & Shibuya M, et al.: Combined effect of L-arginine and superoxide dismutase on the spastic basilar artery after subarachnoid hemorrhage in dogs. J Neurosurg 80:476483, 1994

    • Search Google Scholar
    • Export Citation
  • 35

    Kaneko A, , Moritake K, & Kimura Y: Inhibitory effect of deuterium oxide on cerebral vasospasm after experimental subarachnoid hemorrhage in a rabbit model. Neurol Res 27:446 451, 2005

    • Search Google Scholar
    • Export Citation
  • 36

    Kasuya H, , Onda H, , Takeshita M, , Okada Y, & Hori T: Efficacy and safety of nicardipine prolonged-release implants for preventing vasospasm in humans. Stroke 33:10111015, 2002

    • Search Google Scholar
    • Export Citation
  • 37

    Kasuya H, , Onda H, , Sasahara A, , Takeshita M, & Hori T: Application of nicardipine prolonged-release implants: analysis of 97 consecutive patients with acute subarachnoid hemorrhage. Neurosurgery 56:895902, 2005

    • Search Google Scholar
    • Export Citation
  • 38

    Kato Y: [Effect of intrathecal vitamin E on experimental chronic cerebral vasospasm.]. Zhonghua Nei Ke Za Zhi 23:171173, 1984. (Chn)

  • 39

    Kawada S, , Kinugasa K, , Meguro T, , Hirotsune N, , Tokunaga K, & Kamata I, et al.: Experimental study of intracisternal administration of tissue-type plasminogen activator followed by cerebrospinal fluid drainage in the ultra-early stage of subarachnoid haemorrhage. Acta Neurochir (Wien) 141:13311338, 1999

    • Search Google Scholar
    • Export Citation
  • 40

    Kawamoto S, , Tsutsumi K, , Yoshikawa G, , Shinozaki MH, , Yako K, & Nagata K, et al.: Effectiveness of the head-shaking method combined with cisternal irrigation with urokinase in preventing cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg 100:236243, 2004

    • Search Google Scholar
    • Export Citation
  • 41

    Kawashima A, , Kasuya H, , Shiokawa K, , Miyajima M, , Izawa M, & Takakura K: [Efficacy of nicardipine prolonged-release pellet on cerebral vasospasm in dogs.]. No Shinkei Geka 26:3743, 1998. (Jpn)

    • Search Google Scholar
    • Export Citation
  • 42

    Kemaloglu S, , Ozkan U, , Yilmaz F, , Ak E, , Acemoglu H, & Olmez G, et al.: Preventive effects of intracisternal alphatochopherol on cerebral vasospasm in experimental subarachnoid haemorrhage. Yonsei Med J 44:955960, 2003

    • Search Google Scholar
    • Export Citation
  • 43

    Kudo A, , Suzuki M, , Kubo Y, , Watanabe M, , Yoshida K, & Doi M, et al.: Intrathecal administration of thrombin inhibitor ameliorates cerebral vasospasm. Use of a drug delivery system releasing hirudin. Cerebrovasc Dis 10:424430, 2000

    • Search Google Scholar
    • Export Citation
  • 44

    Kumar R, , Pathak A, , Mathuriya SN, & Khandelwal N: Intraventricular sodium nitroprusside therapy: a future promise for refractory subarachnoid hemorrhage-induced vasospasm. Neurol India 51:197202, 2003

    • Search Google Scholar
    • Export Citation
  • 45

    Leska P, & Krupka J: [Intrathecal administration of antifibrinolytics in subarachnoid hemorrhage.]. Cesk Neurol Neurochir 46:411412, 1983. (Czech)

    • Search Google Scholar
    • Export Citation
  • 46

    Leska P, , Krupka J, , Nakladal J, & Volcik P: [Intrathecal administration of antifibrinolytics in primary subarachnoid hemorrhage during the acute period.]. Cesk Neurol Neurochir 50:1723, 1987. (Czech)

    • Search Google Scholar
    • Export Citation
  • 47

    Lewis PJ, , Weir BK, , Nosko MG, , Tanabe T, & Grace MG: Intrathecal nimodipine therapy in a primate model of chronic cerebral vasospasm. Neurosurgery 22:492500, 1988

    • Search Google Scholar
    • Export Citation
  • 48

    Lin CL, , Jeng AY, , Howng SL, & Kwan AL: Endothelin and subarachnoid hemorrhage-induced cerebral vasospasm: pathogenesis and treatment. Curr Med Chem 11:17791791, 2004

    • Search Google Scholar
    • Export Citation
  • 49

    Lüders JCC, , Lin G, , Ghadge G, , Stoodley M, & Roos RP, et al.: Adenoviral gene transfer of nitric oxide synthase increases cerebral blood flow in rats. Neurosurgery 47:12061215, 2000

    • Search Google Scholar
    • Export Citation
  • 50

    Macdonald RL, , Weir BK, , Runzer TD, , Grace MG, & Poznansky MJ: Effect of intrathecal superoxide dismutase and catalase on oxyhemoglobin-induced vasospasm in monkeys. Neurosurgery 30:529539, 1992

    • Search Google Scholar
    • Export Citation
  • 51

    Macdonald RL, , Zhang ZD, , Curry D, , Elas M, , Aihara Y, & Halpern H, et al.: Intracisternal sodium nitroprusside fails to prevent vasospasm in nonhuman primates. Neurosurgery 51:761770, 2002

    • Search Google Scholar
    • Export Citation
  • 52

    Marbacher S, , Neuschmelting V, , Graupner T, , Jakob SM, & Fandino J: Prevention of delayed cerebral vasospasm by continuous intrathecal infusion of glyceroltrinitrate and nimodipine in the rabbit model in vivo. Intensive Care Med 34:932938, 2008

    • Search Google Scholar
    • Export Citation
  • 53

    Marshman LA: Intracisternal sodium nitroprusside fails to prevent vasospasm in nonhuman primates. Neurosurgery 58:E799, 2006. (Letter)

  • 54

    Mizoi K, , Yoshimoto T, , Fujiwara S, , Sugawara T, , Takahashi A, & Koshu K: Prevention of vasospasm by clot removal and intrathecal bolus injection of tissue-type plasminogen activator: preliminary report. Neurosurgery 28:807813, 1991

    • Search Google Scholar
    • Export Citation
  • 55

    Mizoi K, , Yoshimoto T, , Takahashi A, , Fujiwara S, , Koshu K, & Sugawara T: Prospective study on the prevention of cerebral vasospasm by intrathecal fibrinolytic therapy with tissue-type plasminogen activator. J Neurosurg 78:430437, 1993

    • Search Google Scholar
    • Export Citation
  • 56

    Mizuno T, , Hamada J, , Kai Y, , Todaka T, , Morioka M, & Ushio Y: Intrathecal urokinase infusion through a microcatheter into the cisterna magna to prevent cerebral vasospasm: experimental study in dogs. AJNR Am J Neuroradiol 24:613618, 2003

    • Search Google Scholar
    • Export Citation
  • 57

    Moriyama E, , Matsumoto Y, , Meguro T, , Kawada S, , Mandai S, & Gohda Y, et al.: Combined cisternal drainage and intrathecal urokinase injection therapy for prevention of vasospasm in patients with aneurysmal subarachnoid hemorrhage. Neurol Med Chir (Tokyo) 35:732736, 1995

    • Search Google Scholar
    • Export Citation
  • 58

    Naff NJ, , Hanley DF, , Keyl PM, , Tuhrim S, , Kraut M, & Bederson J, et al.: Intraventricular thrombolysis speeds blood clot resolution: results of a pilot, prospective, randomized, double-blind, controlled trial. Neurosurgery 54:577584, 2004

    • Search Google Scholar
    • Export Citation
  • 59

    Ogata M, , Marshall BM, & Lougheed WM: Observations on the effects of intrathecal papaverine in experimental vasospasm. J Neurosurg 38:2025, 1973

    • Search Google Scholar
    • Export Citation
  • 60

    Ohkuma H, , Parney I, , Megyesi J, , Ghahary A, & Findlay JM: Antisense preproendothelin-oligoDNA therapy for vasospasm in a canine model of subarachnoid hemorrhage. J Neurosurg 90:11051114, 1999

    • Search Google Scholar
    • Export Citation
  • 61

    Ohman J, , Servo A, & Heiskanen O: Effect of intrathecal fibrinolytic therapy on clot lysis and vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 75:197201, 1991

    • Search Google Scholar
    • Export Citation
  • 62

    Ohmoto T, , Yoshioka J, , Shibata K, , Marooka H, , Matsumoto Y, & Nishimoto A: Cerebral vasospasm following subarachnoid hemorrhage—experimental and clinical studies. Neurol Med Chir (Tokyo) 19:7381, 1979

    • Search Google Scholar
    • Export Citation
  • 63

    Ohta T, , Satoh G, & Kuroiwa T: The permeability change of major cerebral arteries in experimental vasospasm. Neurosurgery 30:331336, 1992

    • Search Google Scholar
    • Export Citation
  • 64

    Onoda K, , Ono S, , Ogihara K, , Shiota T, , Asari S, & Ohmoto T, et al.: Inhibition of vascular contraction by intracisternal administration of preproendothelin-1 mRNA antisense oligoDNA in a rat experimental vasospasm model. J Neurosurg 85:846 852, 1996

    • Search Google Scholar
    • Export Citation
  • 65

    Pachl J, , Haninec P, , Tencer T, , Mizner P, , Houst'ava L, & Tomás R, et al.: The effect of subarachnoid sodium nitroprusside on the prevention of vasospasm in subarachnoid haemorrhage. Acta Neurochir Suppl 95:141145, 2005

    • Search Google Scholar
    • Export Citation
  • 66

    Pang D, , Sclabassi R, & Horton J: Lysis of intraventricular blood clot with urokinase in a canine model: Part 3. Effects of intraventricular urokinase on lot lysis and posthemorrhagic hydrocephalus. Neurosurgery 19:553557, 1986

    • Search Google Scholar
    • Export Citation
  • 67

    Pathak A, , Mathuriya SN, , Khandelwal N, & Verma K: Intermittent low dose intrathecal sodium nitroprusside therapy for treatment of symptomatic aneurysmal SAH-induced vasospasm. Br J Neurosurg 17:306310, 2003

    • Search Google Scholar
    • Export Citation
  • 68

    Pradilla G, , Thai Q, , Legnani F, , Clatterbuck R, , Gailloud P, & Murphy K, et al.: Local delivery of ibuprofen via controlledrelease polymers prevents angiographic vasospasm in a monkey model of subarachnoid hemorrhage. Neurosurgery 57:184190, 2005

    • Search Google Scholar
    • Export Citation
  • 69

    Pradilla G, , Thai QA, , Legnani FG, , Hsu W, , Kretzer RM, & Wang PP, et al.: Delayed intracranial delivery of a nitric oxide donor from a controlled-release polymer prevents experimental cerebral vasospasm in rabbits. Neurosurgery 55:13931400, 2004

    • Search Google Scholar
    • Export Citation
  • 70

    Raabe A, , Zimmermann M, , Setzer M, , Vatter H, , Berkefeld J, & Seifert V: Effect of intraventricular sodium nitroprusside on cerebral hemodynamics and oxygenation in poor-grade aneurysm patients with severe, medically refractory vasospasm. Neurosurgery 50:10061014, 2002

    • Search Google Scholar
    • Export Citation
  • 71

    Sasaki T, , Ohta T, , Kikuch H, , Takakura K, , Usui M, & Kondoh A, et al.: [Preliminary clinical trial of intrathecal rt-PA (TD-2061) for the prevention of cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage.]. No To Shinkei 44:10011008, 1992. (Jpn)

    • Search Google Scholar
    • Export Citation
  • 72

    Satoh M, , Perkins E, , Kimura H, , Tang J, , Chun Y, & Heistad D, et al.: Posttreatment with adenovirus-mediated gene transfer of calcitonin gene-related peptide to reverse vasospasm in dogs. J Neurosurg 97:136142, 2002

    • Search Google Scholar
    • Export Citation
  • 73

    Segawa H, , Saito I, , Okada T, , Nagayama I, , Kitamura K, & Takakura K, et al.: Efficacy of intracisternal papaverine on symptomatic vasospasm. Wilkins RH: Cerebral Vasospasm New York, Raven Press, 1988. 433441

    • Search Google Scholar
    • Export Citation
  • 74

    Seifert V: Intrathecal fibrinolysis using recombinant tissue plasminogen activator (rTPA) for prevention of cerebral vasospasm and delayed ischaemic deficits after aneurysmal subarachnoid haemorrhage. Experimental and clinical data. Neurol Res 16:5458, 1994

    • Search Google Scholar
    • Export Citation
  • 75

    Shibata S, , Suzuki S, , Ohkuma H, , Kimura M, & Fujita S: Effects of intracisternal methylprednisolone on lipid peroxidation in experimental subarachnoid hemorrhage. Acta Neurochir (Wien) 141:529532, 1999

    • Search Google Scholar
    • Export Citation
  • 76

    Shibuya M, , Suzuki Y, , Enomoto H, , Okada T, , Ogura K, & Sugita K: Effects of prophylactic intrathecal administrations of nicardipine on vasospasm in patients with severe aneurysmal subarachnoid haemorrhage. Acta Neurochir (Wien) 131:19 25, 1994

    • Search Google Scholar
    • Export Citation
  • 77

    Stolke D, & Seifert V: Single intracisternal bolus of recombinant tissue plasminogen activator in patients with aneurysmal subarachnoid hemorrhage: preliminary assessment of efficacy and safety in an open clinical study. Neurosurgery 30:877881, 1992

    • Search Google Scholar
    • Export Citation
  • 78

    Suzuki H, , Kanamaru K, , Kuroki M, , Sun H, , Waga S, & Miyazawa T: Effects of unilateral intrathecal administrations of low dose tissue-type plasminogen activator on clot lysis, vasospasm and brain phospholipid hydroperoxidation in a primate model of bilateral subarachnoid hemorrhage. Neurol Res 20:625631, 1998

    • Search Google Scholar
    • Export Citation
  • 79

    Suzuki M, , Doi M, , Otawara Y, , Ogasawara K, & Ogawa A: Intrathecal administration of nicardipine hydrochloride to prevent vasospasm in patients with subarachnoid hemorrhage. Neurosurg Rev 24:180184, 2001

    • Search Google Scholar
    • Export Citation
  • 80

    Takanashi Y, , Ishida T, , Meguro T, , Kirchmeier MJ, , Allen TM, & Zhang JH: Intrathecal application with liposome-entrapped Fasudil for cerebral vasospasm following subarachnoid hemorrhage in rats. J Clin Neurosci 8:557561, 2001

    • Search Google Scholar
    • Export Citation
  • 81

    Takanashi Y, , Ishida T, , Meguro T, , Kiwada H, , Zhang JH, & Yamamoto I: Efficacy of intrathecal liposomal fasudil for experimental cerebral vasospasm after subarachnoid hemorrhage. Neurosurgery 48:894901, 2001

    • Search Google Scholar
    • Export Citation
  • 82

    Tanazawa T, , Suzuki Y, , Anzai M, , Tsugane S, , Takayasu M, & Shibuya M: Vasodilation by intrathecal lipopolysaccharide of the cerebral arteries after subarachnoid haemorrhage in dogs. Acta Neurochir (Wien) 138:330337, 1996

    • Search Google Scholar
    • Export Citation
  • 83

    Tekkok IH, , Tekkok S, , Ozcan OE, , Erbengi T, & Erbengi A: Preventive effect of intracisternal heparin for proliferative angiopathy after experimental subarachnoid haemorrhage in rats. Acta Neurochir (Wien) 127:112117, 1994

    • Search Google Scholar
    • Export Citation
  • 84

    Thomas JE, & McGinnis G: Safety of intraventricular sodium nitroprusside and thiosulfate for the treatment of cerebral vasospasm in the intensive care unit setting. Stroke 33:486492, 2002

    • Search Google Scholar
    • Export Citation
  • 85

    Thomas JE, , Nemirovsky A, , Zelman V, & Giannotta SL: Rapid reversal of endothelin-1-induced cerebral vasoconstriction by intrathecal administration of nitric oxide donors. Neurosurgery 40:12451249, 1997

    • Search Google Scholar
    • Export Citation
  • 86

    Thomas JE, & Rosenwasser RH: Reversal of severe cerebral vasospasm in three patients after aneurysmal subarachnoid hemorrhage: initial observations regarding the use of intraventricular sodium nitroprusside in humans. Neurosurgery 44:4858, 1999

    • Search Google Scholar
    • Export Citation
  • 87

    Tierney TS, , Pradilla G, , Wang PP, , Clatterbuck RE, & Tamargo RJ: Intracranial delivery of the nitric oxide donor diethylenetriamine/nitric oxide from a controlled-release polymer: toxicity in cynomolgus monkeys. Neurosurgery 58:952960, 2006

    • Search Google Scholar
    • Export Citation
  • 88

    Toshima M, , Kassell NF, , Tanaka Y, & Dougherty DA: Effect of intracisternal and intravenous calcitonin gene-related peptide on experimental cerebral vasospasm in rabbits. Acta Neurochir (Wien) 119:134138, 1992

    • Search Google Scholar
    • Export Citation
  • 89

    Toyoda K, , Faraci FM, , Watanabe Y, , Ueda T, , Andresen JJ, & Chu Y, et al.: Gene transfer of calcitonin gene-related peptide prevents vasoconstriction after subarachnoid hemorrhage. Circ Res 87:818824, 2000

    • Search Google Scholar
    • Export Citation
  • 90

    Toyoda T, , Kwan AL, , Bavbek M, , Kassell NF, , Wanebo JE, & Lee KS: Enhanced endogenous antioxidant activity and inhibition of cerebral vasospasm in rabbits by pretreatment with a nontoxic endotoxin analog, monophosphoryl lipid A. J Neurosurg 88:10821087, 1998

    • Search Google Scholar
    • Export Citation
  • 91

    Usui M, , Saito N, , Hoya K, & Todo T: Vasospasm prevention with postoperative intrathecal thrombolytic therapy: a retrospective comparison of urokinase, tissue plasminogen activator, and cisternal drainage alone. Neurosurgery 34:235245, 1994

    • Search Google Scholar
    • Export Citation
  • 92

    Vajkoczy P, , Hubner U, , Horn P, , Bauhuf C, , Thome C, & Schilling L, et al.: Intrathecal sodium nitroprusside improves cerebral blood flow and oxygenation in refractory cerebral vasospasm and ischemia in humans. Stroke 31:11951197, 2000

    • Search Google Scholar
    • Export Citation
  • 93

    Varelas PN, , Rickert KL, , Cusick J, , Hacein-Bey L, , Sinson G, & Torbey M, et al.: Intraventricular hemorrhage after aneurysmal subarachnoid hemorrhage: pilot study of treatment with intraventricular tissue plasminogen activator. Neurosurgery 56:205213, 2005

    • Search Google Scholar
    • Export Citation
  • 94

    Voldby B, , Petersen OF, , Buhl M, , Jakobsen P, & Ostergaard R: dog: Reversal of cerebral arterial spasm by intrathecal administration of a calcium antagonist (nimodipine). Acta Neurochir (Wien) 70:243254, 1984

    • Search Google Scholar
    • Export Citation
  • 95

    Watanabe Y, , Chu Y, , Andresen JJ, , Nakane H, , Faraci FM, & Heistad DD: Gene transfer of extracellular superoxide dismutase reduces cerebral vasospasm after subarachnoid hemorrhage. Stroke 34:434440, 2003

    • Search Google Scholar
    • Export Citation
  • 96

    Wolf EW, , Banerjee A, , Soble-Smith J, , Dohan FC Jr, , White RP, & Robertson JT: Reversal of cerebral vasospasm using an intrathecally administered nitric oxide donor. J Neurosurg 89:279288, 1998

    • Search Google Scholar
    • Export Citation
  • 97

    Yoshida Y, , Ueki S, , Takahashi A, , Takagi H, , Torigoe H, & Kudo S: [Intrathecal irrigation with urokinase in ruptured cerebral aneurysm cases. Basic study and clinical application.]. Neurol Med Chir (Tokyo) 25:989997, 1985. (Jpn)

    • Search Google Scholar
    • Export Citation
  • 98

    Zabramski J, , Spetzler RF, & Bonstalle C: Chronic cerebral vasospasm: effect of calcium antagonists. Neurosurgery 18:129 135, 1986

  • 99

    Zimmermann M, , Jung C, , Raabe A, , Spanehl O, , Fach K, & Seifert V: Inhibition of endothelin-converting enzyme activity in the rabbit basilar artery. Neurosurgery 48:902910, 2001

    • Search Google Scholar
    • Export Citation
  • 1

    Aihara Y, , Jahromi BS, , Yassari R, , Sayama T, & Macdonald RL: Effects of a nitric oxide donor on and correlation of changes in cyclic nucleotide levels with experimental vasospasm. Neurosurgery 52:661667, 2003

    • Search Google Scholar
    • Export Citation
  • 2

    Amin-Hanjani S, , Ogilvy C, & Barker F II: Does intracisternal thrombolysis prevent vasospasm after aneurysmal subarachnoid hemorrhage? A meta-analysis. Neurosurgery 54:326 335, 2004

    • Search Google Scholar
    • Export Citation
  • 3

    Asano T, , Sasaki T, , Koide T, , Takakura K, & Sano K: Experimental evaluation of the beneficial effect of an antioxidant on cerebral vasospasm. Neurol Res 6:4953, 1984

    • Search Google Scholar
    • Export Citation
  • 4

    Auer LM: Preventive nimodipine and acute aneurysm surgery. Heading for the control of complications after aneurysmal subarachnoid hemorrhage. Neurochirurgia (Stuttg) 28:8792, 1985

    • Search Google Scholar
    • Export Citation
  • 5

    Berg SL, & Chamberlain MC: Current treatment of leptomeningeal metastases: systemic chemotherapy, intrathecal chemotherapy and symptom management. Cancer Treat Res 125:121146, 2005

    • Search Google Scholar
    • Export Citation
  • 6

    Boullin DJ, , Adams CB, , Mohan J, , Green AR, , Hunt TM, & du Boulay GH, et al.: Effects of intracranial dopamine perfusion: hbehavioural arousal and reversal of cerebral arterial spasm following surgery for clipping of ruptured cerebral aneurysms. Proc R Soc Med 70:Suppl 2 5570, 1977

    • Search Google Scholar
    • Export Citation
  • 7

    Cosentino F, , McMahon EG, , Carter JS, & Katusic ZS: Effect of endothelinA-receptor antagonist BQ-123 and phosphoramidon on cerebral vasospasm. J Cardiovasc Pharmacol 22:Suppl 8 S332S335, 1993

    • Search Google Scholar
    • Export Citation
  • 8

    Elkersh MA, , Simopoulos TT, & Bajwa ZH: Fundamentals of interventional pain medicine. Neurologist 11:285293, 2005

  • 9

    Espinosa F, , Weir B, , Overton T, , Castor W, , Grace M, & Boisvert O: A randomized placebo-controlled double-blind trial of nimodipine after SAH in monkeys. Part I: clinical and radiological findings. J Neurosurg 60:11671175, 1984

    • Search Google Scholar
    • Export Citation
  • 10

    Findlay JM, , Kassell NF, , Weir BK, , Haley EC Jr, , Kongable G, & Germanson T, et al.: A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm. Neurosurgery 37:168178, 1995

    • Search Google Scholar
    • Export Citation
  • 11

    Findlay JM, , Weir BK, , Gordon P, , Grace M, & Baughman R: Safety and efficacy of intrathecal thrombolytic therapy in a primate model of cerebral vasospasm. Neurosurgery 24:491 498, 1989

    • Search Google Scholar
    • Export Citation
  • 12

    Fisher CM, , Kistler JP, & Davis JM: Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 6:19, 1980

    • Search Google Scholar
    • Export Citation
  • 13

    Follett KA, , Boortz-Marx RL, , Drake JM, , DuPen S, , Schneider SJ, & Turner MS, et al.: Prevention and management of intrathecal drug delivery and spinal cord stimulation system infections. Anesthesiology 100:15821594, 2004

    • Search Google Scholar
    • Export Citation
  • 14

    Fujiwara K, , Mikawa S, & Ebina T: [Continuous intrathecal administration of nicardipine using a portable infusion pump system for management of vasospasm after subarachnoid hemorrhage.]. No Shinkei Geka 29:2330, 2001

    • Search Google Scholar
    • Export Citation
  • 15

    Gioia AE, , White RP, , Bakhtian B, & Robertson JT: Evaluation of the efficacy of intrathecal nimodipine in canine models of chronic cerebral vasospasm. J Neurosurg 62:721728, 1985

    • Search Google Scholar
    • Export Citation
  • 16

    Hamada J, , Mizuno T, , Kai Y, , Morioka M, & Ushio Y: Microcatheter intrathecal urokinase infusion into cisterna magna for prevention of cerebral vasospasm: preliminary report. Stroke 31:21412148, 2000

    • Search Google Scholar
    • Export Citation
  • 17

    Hariton GB, , Findlay JM, , Weir BK, , Kasuya H, , Grace MG, & Mielke BW: Comparison of intrathecal administration of urokinase and tissue plasminogen activator on subarachnoid clot and chronic vasospasm in a primate model. Neurosurgery 33:691697, 1993

    • Search Google Scholar
    • Export Citation
  • 18

    Heidrich R, , Markwardt F, , Endler S, & Hindersin P: Antifibrinolytic therapy of subarachnoid hemorrhage by intrathecal administration of p-aminomethylbenzoic acid. J Neurol 219:8385, 1978

    • Search Google Scholar
    • Export Citation
  • 19

    Hino A, , Weir BK, , Macdonald RL, , Thisted RA, , Kim CJ, & Johns LM: Prospective, randomized, double-blind trial of BQ-123 and bosentan for prevention of vasospasm following subarachnoid hemorrhage in monkeys. J Neurosurg 83:503509, 1995

    • Search Google Scholar
    • Export Citation
  • 20

    Kaplan KM, & Brose WG: Intrathecal methods. Neurosurg Clin N Am 15:289296, vi, 2004

  • 21

    Kawamoto S, , Tsutsumi K, , Yoshikawa G, , Shinozaki MH, , Yako K, & Nagata K, et al.: Effectiveness of the head-shaking method combined with cisternal irrigation with urokinase in preventing cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg 100:236243, 2004

    • Search Google Scholar
    • Export Citation
  • 22

    Kırış T, , Erden T, , Sahinbas M, , Omay B, & Esen F, CSF drainage for prevention and reversal of cerebral vasospasm after surgical treatment of intracranial aneurysms. Macdonald RL: Cerebral Vasospasm: Advances in Research and Treatment New York, Thieme, 2005. 255258

    • Search Google Scholar
    • Export Citation
  • 23

    Klimo P, , Kestle J, , MacDonald J, & Schmidt R: Marked reduction of cerebral vasospasm with lumbar drainage of cerebrospinal fluid after subarachnoid hemorrhage. J Neurosurg 100:215224, 2004

    • Search Google Scholar
    • Export Citation
  • 24

    Kramer AH, , Hehir M, , Nathan B, , Gress D, , Dumont AS, & Kassell NF, et al.: A comparison of 3 radiographic scales for the prediction of delayed ischemia and prognosis following subarachnoid hemorrhage. J Neurosurg 109:199207, 2008

    • Search Google Scholar
    • Export Citation
  • 25

    Lewis PJ, , Weir BK, , Nosko MG, , Tanabe T, & Grace MG: Intrathecal nimodipine therapy in a primate model of chronic cerebral vasospasm. Neurosurgery 22:492500, 1988

    • Search Google Scholar
    • Export Citation
  • 26

    Lin CL, , Jeng AY, , Howng SL, & Kwan AL: Endothelin and subarachnoid hemorrhage-induced cerebral vasospasm: pathogenesis and treatment. Curr Med Chem 11:17791791, 2004

    • Search Google Scholar
    • Export Citation
  • 27

    Macdonald RL, , Zhang Z-D, , Curry D, , Elas M, , Aihara Y, & Halpern H, et al.: Intracisternal sodium nitroprusside fails to prevent vasospasm in nonhuman primates. Neurosurgery 51:761770, 2002

    • Search Google Scholar
    • Export Citation
  • 28

    Megyesi JF, , Vollrath B, , Cook DA, & Findlay JM: In vivo animal models of cerebral vasospasm: a review. Neurosurgery 46:448461, 2000

  • 29

    Miles J: Intrathecal treatment for spasticity. Stereotact Funct Neurosurg 76:246248, 2001

  • 30

    Naff NJ, , Williams MA, , Rigamonti D, , Keyl PM, & Hanley DF: Blood clot resolution in human cerebrospinal fluid: evidence of first-order kinetics. Neurosurgery 49:614621, 2001

    • Search Google Scholar
    • Export Citation
  • 31

    Nakagomi T, , Takagi K, , Narita K, , Nagashima H, & Tamura A: Cisternal washing therapy for the prevention of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Acta Neurochir Suppl 77:161165, 2001

    • Search Google Scholar
    • Export Citation
  • 32

    Ogata M, , Marshall BM, & Lougheed WM: Observations on the effects of intrathecal papaverine in experimental vasospasm. J Neurosurg 38:2025, 1973

    • Search Google Scholar
    • Export Citation
  • 33

    Ohta T, , Satoh G, & Kuroiwa T: The permeability change of major cerebral arteries in experimental vasospasm. Neurosurgery 30:331336, 1992

    • Search Google Scholar
    • Export Citation
  • 34

    Penn RD: Intrathecal medication delivery. Neurosurg Clin N Am 14:381387, 2003

  • 35

    Pluta RM, , Dejam A, , Grimes G, , Gladwin MT, & Oldfield EH: Nitrite infusions prevent cerebral artery vasospasm in a primate model of subarachnoid aneurismal hemorrhage. JAMA 293:14771484, 2005

    • Search Google Scholar
    • Export Citation
  • 36

    Pradilla G, , Wang P, , Legnani F, , Frazier J, & Tamargo R: Pharmacokinetics of controlled-release polymers in the subarachnoid space after subarachnoid hemorrhage in rabbits. J Neurosurg 101:99103, 2004

    • Search Google Scholar
    • Export Citation
  • 37

    Proescholdt MG, , Hutto B, , Brady L, & Herkenham M: Studies of cerebrospinal fluid flow and penetration into brain following lateral ventricle and cisterna magna injections of the tracer [14C] inulin. Neuroscience 95:577592, 2000

    • Search Google Scholar
    • Export Citation
  • 38

    Raabe A, , Zimmermann M, , Setzer M, , Vatter H, , Berkefeld J, & Seifert V: Effect of intraventricular sodium nitroprusside on cerebral hemodynamics and oxygenation in poor-grade aneurysm patients with severe, medically refractory vasospasm. Neurosurgery 50:10061014, 2002

    • Search Google Scholar
    • Export Citation
  • 39

    Shibuya M, , Suzuki Y, , Enomoto H, , Okada T, , Ogura K, & Sugita K: Effects of prophylactic intrathecal administrations of nicardipine on vasospasm in patients with severe aneurysmal subarachnoid haemorrhage. Acta Neurochir (Wien) 131:19 25, 1994

    • Search Google Scholar
    • Export Citation
  • 40

    Stoodley M, , MacDonald RL, , Weir B, , Marton LS, , Johns L, & Du Zhang Z, et al.: Subarachnoid hemorrhage as a cause of an adaptive response in cerebral arteries. J Neurosurg 93:463 470, 2000

    • Search Google Scholar
    • Export Citation
  • 41

    Tekkok IH, , Tekkok S, , Ozcan OE, , Erbengi T, & Erbengi A: Preventive effect of intracisternal heparin for proliferative angiopathy after experimental subarachnoid haemorrhage in rats. Acta Neurochir (Wien) 127:112117, 1994

    • Search Google Scholar
    • Export Citation
  • 42

    Thomas JE, & Rosenwasser RH: Reversal of severe cerebral vasospasm in three patients after aneurysmal subarachnoid hemorrhage: initial observations regarding the use of intraventricular sodium nitroprusside in humans. Neurosurgery 44:4858, 1999

    • Search Google Scholar
    • Export Citation
  • 43

    Vajkoczy P, , Hubner U, , Horn P, , Bauhuf C, , Thome C, & Schilling L, et al.: Intrathecal sodium nitroprusside improves cerebral blood flow and oxygenation in refractory cerebral vasospasm and ischemia in humans. Stroke 31:11951197, 2000

    • Search Google Scholar
    • Export Citation
  • 44

    Varelas PN, , Rickert KL, , Cusick J, , Hacein-Bey L, , Sinson G, & Torbey M, et al.: Intraventricular hemorrhage after aneurysmal subarachnoid hemorrhage: pilot study of treatment with intraventricular tissue plasminogen activator. Neurosurgery 56:205213, 2005

    • Search Google Scholar
    • Export Citation
  • 45

    Voldby B, , Petersen OF, , Buhl M, , Jakobsen P, & Ostergaard R: Reversal of cerebral arterial spasm by intrathecal administration of a calcium antagonist (nimodipine). Acta Neurochir (Wien) 70:243254, 1984

    • Search Google Scholar
    • Export Citation
  • 46

    Weir B, , Grace M, , Hansen J, & Rothberg C: Time course of vasospasm in man. J Neurosurg 48:173178, 1978

  • 47

    Zhang ZD, , Yamini B, , Komuro T, , Ono S, , Johns L, & Marton LS, et al.: Vasospasm in monkeys resolves because of loss of and encasement of subarachnoid blood clot. Stroke 32:18681874, 2001

    • Search Google Scholar
    • Export Citation
  • 48

    Zimmermann M, , Jung C, , Raabe A, , Spanehl O, , Fach K, & Seifert V: Inhibition of endothelin-converting enzyme activity in the rabbit basilar artery. Neurosurgery 48:902910, 2001

    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 401 95 4
Full Text Views 248 26 0
PDF Downloads 135 22 0
EPUB Downloads 0 0 0